Page 7 - WJOLS
P. 7

Laparoscopic Ultrasound–Guided versus Percutaneous Radiofrequency Ablation in Treatment of Unresectable HCC





















                        Fig. 9: In case of tumors bulging on liver surface, the hilar portion of the tumor was ablated initially in order
                                             to destroy the inflow of blood supplying the tumor























                      Fig. 10: Intraoperative US monitoring: Picture to the left showing RF Needle’s umbrella opened inside the tumor.
                                           The one to the right shows the tissues after ablation


            Intraoperative Ultrasound Monitoring               antiemetic was given as all patients experienced post-ablation
                                                               nausea. Strong IV analgesics were given to control pain as
            The ultrasound probes used as a guide for any residual lesion,  pethidine hydrochloride 50 mg (pethidine) or tramadol
            it allows measure the zone of increased echogenicity corres-  hydrochloride 50 mg (tramadol). Prophylactic IV antibiotic were
            ponding to the coagulation of the tissues (Fig. 10).
                                                               started, amoxicillin-clavulanic acid (augmentin) or ceftazidine
                                                               (fortum), and metronidazole, and continued for 24 hours. Before
            Ending RFA Treatment
                                                               leaving the surgery department US examination was performed
            After complete ablation of the tumour was achieved, the arrays  to the patients to detect any collection. The patient was allowed
            were completely retracted. The needle track was ablated as the  to eat within 24 hours.
            needle electrode was withdrawn, and then the needle electrode
            was removed. The skin incisions were closed by sutures, steri-  Follow-up
            lized and dressed. Patients were allowed to recover.
                                                               All patients were followed for 24 months for: Hospital stay; Pro-
                                                               cedure related complications; Early pos-tablation complications
            Postablation Care
                                                               (first month); Tumour volume response; Tumour marker res-
            All patients were observed for 24 hours in the surgery depart-  ponse; Late complications; Tumour recurrence and distant meta-
            ment to detect any acute complications and to start IV fluid. IV  stases; Two years–over all survival and disease free survival.


                                                             5
   2   3   4   5   6   7   8   9   10   11   12